l General Information |
Product Name | Favipiravir |
General description | Favipiravir is a potent and selective RNA-dependent RNA polymerase inhibitor, used to treat influenza virus infections. |
Synonym | T-705 |
Purity | ≥98.5%(HPLC) | CAS Number | 259793-96-9 |
Formula | C5H4FN3O2 | Molecular Weight | 157.1 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥25mg/mL |
Ethanol | ≥15mg/mL |
Water | ~5mg/mL |
l Biological Information |
Biochem/Physiol
Actions | Favipiravir is a pyrazinecarboxamide derivative with activity against RNA viruses. Favipiravir is converted to the ribofuranosyltriphosphate derivative by host enzymes and selectively inhibits the influenza viral RNA-dependent RNA polymerase. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
